Skip to main content

Bailard, Inc.

SEC CIK
0000750641
Latest filing
Jul 30, 2026

KLRS holding history

Kalaris Therapeutics, Inc. in every 13F filed by Bailard, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KLRS overviewAll 13F holders of KLRSFull Q2 2026 holdings

Shares (Q4 2022)
0
Sold out in Q4 2022
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q2 2022
Holdings of KLRS by Bailard, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20220$00.0%−21,900−100.0%Sold outHolders
Q3 202221,900$173.0K<0.1%00.0%UnchangedHolders
Q2 202221,900$85.0K<0.1%+21,900NewHolders